OPC-262

DRUG3 trials

Sponsors

Kyowa Kirin Co., Ltd.

Conditions

Diabetes, Type 2Type 2 Diabetes

Phase 3

A Study of OPC-262 in Patients With Type 2 Diabetes

CompletedNCT01046318

Kyowa Kirin Co., Ltd.Type 2 Diabetes

Start: 2009-11-30End: 2011-07-31Updated: 2014-01-08

A Phase 3 Study of OPC-262 in Patients With Type 2 Diabetes

CompletedNCT01193179

Kyowa Kirin Co., Ltd.Diabetes, Type 2

Start: 2010-07-31End: 2012-04-30Target: 450Updated: 2014-01-08

Along-term Study of OPC-262 in Patients With Type 2 Diabetes

CompletedNCT01634282

Kyowa Kirin Co., Ltd.Diabetes, Type 2

Start: 2009-08-31End: 2011-06-30Updated: 2014-01-08